Tissue-specific regulation of IGF-I and IGF-binding proteins in response to TNFα

Growth Hormone and IGF Research

Volumn 11, Issue 4, 2001, Pages 250-260

  Lang, Charles H ^a   Nystrom, Gerald J ^a   Frost, Robert A ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

ALS; Free IGF I; IGF II; IGFBP 1; IGFBP 3; mac25

Indexed keywords

DRUG VEHICLE; MAC25 PROTEIN; MESSENGER RNA; MUSCLE PROTEIN; RECOMBINANT TUMOR NECROSIS FACTOR ALPHA; SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN BINDING PROTEIN RELATED PROTEIN 1; SOMATOMEDIN C; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; COMPLEX FORMATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; GASTROCNEMIUS MUSCLE; HEART; KIDNEY; LIVER; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DEGRADATION; PROTEIN SYNTHESIS; RAT; SOLEUS MUSCLE; TISSUE METABOLISM;

EID: 0035186135     PISSN: 10966374     EISSN: None     Source Type: Journal    
DOI: 10.1054/ghir.2001.0233     Document Type: Article

References (52)

1. Regulation of insulin-like growth factor-I (IGF-I) and IGF-binding proteins by tumor necrosis factor
2. Insulin-like growth factor-I improves glucose utilization in tumor necrosis factor-treated rats under hyperinsulinemic-euglycemic conditions
3. Effect of chronic excess of tumour necrosis factor-alpha on contractile proteins in rat skeletal muscle
4. Endotoxin-induced decrease in muscle protein synthesis is associated with changes in eIF2B, eIF4E, and IGF-I
5. Increased protein synthesis after acute IGF-I or insulin infusion is localized to muscle in mice
6. Modulation of inflammation-induced changes in insulin-like growth factor (IGF)-I and IGF binding protein-1 by anti-TNF antibody
7. Inhibition by interleukin-1β and tumor necrosis factor-α of the insulin-like growth factor I messenger ribonucleic acid response to growth hormone in rat hepatocyte primary culture
8. Transient exposure of human myoblasts to TNFα inhibits serum and IGF-I stimulated protein synthesis
9. Insulin-like growth factor-binding proteins in serum and other biological fluids: Regulation and functions
10. Regulation and function of insulin-like growth factor binding protein-1
11. Interleukin-1α (IL-1α) and tumor necrosis factor α (TNFα) regulate insulin-like growth factor binding protein-1 (IGFBP-1) levels and mRNA abundance in vivo and in vitro
12. Regulation of insulin-like growth factor binding protein-1 in HepG2 cells by cytokines and reactive oxygen species
13. Inhibition of insulin receptor activation by insulin-like growth factor binding proteins
14. Tumor necrosis factor impairs insulin action on peripheral glucose disposal and hepatic glucose output
15. Role of tumor necrosis factor-α in the pathophysiologic alterations after hepatic ischemia-reperfusion injury in the rat
16. Prognostic values of tumor necrosis factor/cachectin, interleukin-1, interferon-α, and interferon-γ in the serum of patients with septic shock
17. Tumor necrosis factor-α mediates changes in tissue protein turnover in a rat cancer cachexia model
18. Circulating interleukin-1β and tumor necrosis factor-α concentrations after burn injury in humans
19. Free insulin-like growth factors (IGF-I and IGF-II) in human serum
20. Effect of short-term fasting on free/dissociable IGF-I concentrations in normal human serum
21. Acute response of IGF-I and IGF binding proteins induced by thermal injury
22. Developmental changes in serum levels of free and total insulin-like growth factor I (IGF-I), IGF-binding protein-1 and -3, and the acid-labile subunit in rats
23. Hepatic production and intestinal uptake of IGF-I: Response to infection
24. Liver-derived insulin-like growth factor-I (IGF-I) is the principal source of IGF-I in blood but is not required for postnatal body growth in mice
25. The insulin-like growth factor-binding protein (IGFBP) superfamily
26. Growth hormone and the insulin-like growth factor system in myogenesis
27. Alterations in hepatic production and peripheral clearance of IGF-I after endotoxin
28. Interleukin-1 receptor antagonist attenuates sepsis-induced alterations in the insulin-like growth factor system and protein synthesis
29. Endotoxin-induced inhibition of growth hormone receptor signaling in rat liver in vivo
30. GH insensitivity induced by endotoxin injection is associated with decreased liver GH receptors
31. Potentiation of growth hormone-induced liver suppressors of cytokine signaling messenger ribonucleic acid by cytokines
32. Endotoxin-induced changes in IGF-I differ in rats provided enteral versus parenteral nutrition
33. Regulation of insulin-like growth factor (IGF)-I mRNA and peptide, and IGF binding proteins by interleukin-1
34. Insulin rapidly inhibits insulin-like growth factor-binding protein-1 gene expression in H4-II-E rat hepatoma cells
35. Wasting in the acquired immune deficiency syndrome is associated with multiple defects in the serum insulin-like growth factor system
36. Impaired glucose homeostasis in insulin-like growth factor binding protein-1 transgenic mice
37. Differential effect of IGF-I and IGFBP-1 on protein metabolism in skeletal muscle cells
38. Growth factors in critical illness: Regulation and therapeutic aspects
39. Reduction in circulating IGF-I and hepatic IGF-I mRNA levels after caecal ligation and puncture are associated with differential regulation of hepatic IGF-binding protein-1, -2 and -3 mRNA levels
40. Dexamethasone stimulation of rat insulin-like growth factor binding protein-1 promoter activity involves multiple cis-elements
41. Effects of glucocorticoids on circulating levels and hepatic expression of insulin-like growth factor (IGF)-binding proteins and IGF-I in the adrenalectomized streptozotocin-diabetic rat
42. Growth hormone (GH) regulation of circulating insulin-like growth factor-I levels during sexual maturation of the GH-deficient dwarf (dw/dw) male rat
43. The regulation of insulin-like growth factor-binding protein-1 messenger ribonucleic acid in cultured rat hepatocytes: The roles of glucagon and growth hormone
44. A paradoxical gender dissociation within the growth hormone/insulin-like growth factor I axis during protected critical illness
45. Insulin-like growth factor-binding protein-3 proteolysis is induced after elective surgery
46. Increased proteolysis of insulin-like growth factor-binding protein-3 (IGFBP-3) in noninsulin-dependent diabetes mellitus serum, with elevation of a 29-kilodalton (kDa) glycosylated IGFBP-3 fragment contained in the 130-to 150-kDa ternary complex
47. In vivo proteolysis of serum insulin-like growth factor (IGF) binding protein-3 results in increased availability of IGF to target cells
48. Inactivation of the acid labile subunit gene in mice results in mild retardation of postnatal growth despite profound disruptions in the circulating insulin-like growth factor system
49. Growth hormone stimulates transcription of the gene encoding the acid-labile subunit (ALS) of the circulating insulin-like growth factor-binding protein complex and ALS promoter activity in rat liver
50. Interleukin-1β suppresses growth hormone-induced acid-labile subunit mRNA levels and secretion in primary hepatocytes
51. Role of the suppressor of cytokine signaling-3 in mediating the inhibitory effects of interleukin-1β on the growth hormone-dependent transcription of the acid-labile subunit gene in liver cells
52. IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance